Skip Navigation
NPR News

Using Genetics to Target Cancer's Achilles' Heel

Jan 11, 2013 (Talk of the Nation) — To develop more effective treatments for cancer, doctors are zeroing in on the disease's genetic drivers. John DiPersio, chief of oncology at Washington University Medical Center, and Merck's Gary Gilliland discuss how this may revolutionize the future of cancer treatment.

Hear this

This text will be replaced
Launch in player

Share this

Explore this

Reported by


John DiPersio, Chief, Division of Oncology, Washington University School of Medicine, Barnes-Jewish Hospital Deputy Director, Siteman Cancer Center, St. Louis, Missouri Gary Gilliland, Senior Vice President and Global Head of Oncology, Merck & Co., North Wales, Pennsylvania

Read full story transcript

Missing some content? Check the source: NPR
Copyright(c) 2014, NPR

Visitor comments


NCPR is supported by:

This is a Visitor-Supported website.